{"entity":{"id":"da-term-aria","kind":"term","name":"ARIA","aka":["amyloid-related imaging abnormalities"],"tldr":"ARIA is swelling or bleeding seen on MRI in people receiving amyloid antibodies. It can be silent or, less often, symptomatic.","summary":"ARIA-E is oedema. ARIA-H is haemorrhage. Risk is higher in ApoE ε4 carriers. Monitoring schedules live on the product label, not on this glossary card.","asOf":"2026-09-21","links":[{"label":"FDA Leqembi","url":"https://www.fda.gov/news-events/press-announcements/fda-converts-novel-alzheimers-disease-treatment-traditional-approval"}],"tags":["dementia-atlas"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":["da-lecanemab","da-donanemab"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"category":"Side effects"},"route":"/terms/da-term-aria/","neighbours":{"drug":[{"id":"da-donanemab","kind":"drug","name":"Donanemab","route":"/drugs/da-donanemab/"},{"id":"da-lecanemab","kind":"drug","name":"Lecanemab","route":"/drugs/da-lecanemab/"}],"cancer":[{"id":"alzheimers-disease","kind":"cancer","name":"Alzheimer’s disease","route":"/diagnoses/alzheimers-disease/"}],"pairing":[{"id":"da-pair-lecanemab-mri","kind":"pairing","name":"Lecanemab with MRI monitoring","route":"/pairings/da-pair-lecanemab-mri/"}]}}